Informazioni sul dominio e sul sito Web:
permax.it
Nome del dominio - permax.it
Titolo del sito - Permax – Forniture per laboratori scientifici
Vai al sito web - Permax – Forniture per laboratori scientifici
Posizione GEO del sito
Posizione Paese - Italy
Fornitore - Server Plan S.r.l.
Site Logo
indirizzo IP:
Server dei nomi di dominio:
ns2.nomeasy.com ns1.nomeasy.com
Tutti i record:
☆ permax.it. 3594 IN MX 0 permax-it.mail.protection.outlook.com.
☆ permax.it. 21594 IN NS ns2.nomeasy.com.
☆ permax.it. 594 IN A 77.39.212.161
☆ permax.it. 3594 IN TXT "MS=ms81706921"
☆ permax.it. 3594 IN TXT "v=spf1 include:spf.protection.outlook.com include:turbo-smtp.com -all"
☆ permax.it. 21594 IN NS ns1.nomeasy.com.
☆ permax.it. 21594 IN SOA ns1.nomeasy.com. postmaster.permax.it. 2023112816 14400 3600 1209600 86400
Brief facts about permax:
Pergolide, sold under the brand name Permax and Prascend among others, is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease. Parkinson's disease is associated with reduced dopamine activity in the substantia nigra of the brain. Pergolide acts on many of the same receptors as dopamine to increase receptor activity. It was patented in 1978 and approved for medical use in 1989. In 2007, pergolide was withdrawn from the U.S. market for human use after several published studies revealed a link between the drug and increased rates of valvular heart disease. However, a veterinary form of pergolide, marketed under the trade name Prascend, is permitted for the treatment of pituitary pars intermedia dysfunction also known as equine Cushing's syndrome in horses.
© DMS 2011-